Related Experiment Videos
Predictors of late asthmatic response. Logistic regression and classification tree analyses
Summary
A methacholine challenge test (PC20) below 0.25 mg/ml predicts late asthmatic responses (LAR). Early FEV1 decline also indicates LAR risk, suggesting PC20 as a screening tool for identifying asthma patients likely to experience LAR.
Area of Science:
- Pulmonary Medicine
- Allergy and Immunology
Background:
- Late asthmatic response (LAR) is a significant feature of asthma, impacting disease severity and treatment.
- Predicting LAR is crucial for effective asthma management and patient stratification.
Purpose of the Study:
- To identify predictors of the late asthmatic response (LAR) following allergen challenge.
- To evaluate the utility of methacholine challenge testing (PC20) and early FEV1 decline as predictors of LAR.
Main Methods:
- Retrospective analysis of data from 60 asthma patients undergoing allergen challenge.
- Assessment of baseline FEV1, PC20 methacholine, sputum eosinophils, and early FEV1 decline as potential predictors.
- Logistic regression and classification tree analysis to determine significant predictors of LAR.
Main Results:
- A PC20 methacholine threshold of 0.25 mg/ml was a significant predictor of LAR (OR=0.14).
- A greater decrease in FEV1 within 20 minutes of allergen challenge also predicted LAR (OR=1.18).
- Baseline FEV1 and sputum eosinophil percentage did not significantly predict LAR.
Conclusions:
- PC20 methacholine is a valuable predictor of LAR, with a threshold of 0.25 mg/ml being particularly indicative.
- Measuring PC20 methacholine can serve as an efficient screening method to identify asthma patients at risk for LAR.